Fierce Pharma Biopharma News Insights Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance
JPM26, Day 1: BMS CEO touts portfolio of blockbuster hopefuls After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco for the industry's big | After a flurry of Big Pharma deals in the
Pharma | Fierce Pharma President Donald Trump has approved a plan to fire FDA Commissioner Marty Makary, M D , The Wall Street Journal reports
Top 20 pharma companies by 2024 revenue With only one of the biopharma industry’s top 20 revenue companies seeing a year-over-year decline in sales, 2024 was a remarkable year of revenue growth for the industry Compare that to 2023
